148 related articles for article (PubMed ID: 35597996)
1. KMT2B promotes the growth of renal cell carcinoma via upregulation of SNHG12 expression and promotion of CEP55 transcription.
Feng JF; Wang J; Xie G; Wang YD; Li XH; Yang WY; Yang YW; Zhang B
Cancer Cell Int; 2022 May; 22(1):197. PubMed ID: 35597996
[TBL] [Abstract][Full Text] [Related]
2. Exosomal lncRNA SNHG12 promotes angiogenesis and breast cancer progression.
Chen Y; Zhou Y; Chen J; Yang J; Yuan Y; Wu W
Breast Cancer; 2024 Jul; 31(4):607-620. PubMed ID: 38833118
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
[TBL] [Abstract][Full Text] [Related]
4. lncRNA small nucleolar RNA host gene 12 promotes renal cell carcinoma progression by modulating the miR‑200c‑5p/collagen type XI α1 chain pathway.
Xu C; Liang H; Zhou J; Wang Y; Liu S; Wang X; Su L; Kang X
Mol Med Rep; 2020 Nov; 22(5):3677-3686. PubMed ID: 32901847
[TBL] [Abstract][Full Text] [Related]
5. Pro-Angiogenic and Pro-Inflammatory Regulation by lncRNA MCM3AP-AS1-Mediated Upregulation of DPP4 in Clear Cell Renal Cell Carcinoma.
Qiu L; Ma Y; Yang Y; Ren X; Wang D; Jia X
Front Oncol; 2020; 10():705. PubMed ID: 32714856
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG12 promotes proliferation and epithelial mesenchymal transition in hepatocellular carcinoma through targeting HEG1 via miR-516a-5p.
Chen PP; Zhang ZS; Wu JC; Zheng JF; Lin F
Cell Signal; 2021 Aug; 84():109992. PubMed ID: 33774129
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
8. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
9. SNHG12/miR-326/E2F1 feedback loop facilitates the progression of oral squamous cell carcinoma.
Yin Y; Tan Y; Yao Y; Lu N; Zhang F
Oral Dis; 2020 Nov; 26(8):1631-1639. PubMed ID: 32506729
[TBL] [Abstract][Full Text] [Related]
10. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y
Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expression via sponging miR-15a-5p.
Yuan JH; Li WX; Hu C; Zhang B
Neoplasma; 2020 Jul; 67(4):861-870. PubMed ID: 32386479
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of lncRNA SNHG12 predicts a poor prognosis of nasopharyngeal carcinoma and regulates cell proliferation and metastasis by modulating Notch signal pathway.
Liu ZB; Tang C; Jin X; Liu SH; Pi W
Cancer Biomark; 2018; 23(4):603-613. PubMed ID: 30452404
[TBL] [Abstract][Full Text] [Related]
13. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
14. ZIC2 upregulates lncRNA SNHG12 expression to promote endometrial cancer cell proliferation and migration by activating the Notch signaling pathway.
Cai P; Li G; Wu M; Zhang B; Bai H
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278490
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of SNHG12 regulates the viability and invasion of renal cell carcinoma cells through modulation of HIF1α.
Chen Q; Zhou W; Du SQ; Gong DX; Li J; Bi JB; Li ZH; Zhang Z; Li ZL; Liu XK; Kong CZ
Cancer Cell Int; 2019; 19():128. PubMed ID: 31114448
[TBL] [Abstract][Full Text] [Related]
16. Tumor promoting effects of circRNA_001287 on renal cell carcinoma through miR-144-targeted CEP55.
Feng J; Guo Y; Li Y; Zeng J; Wang Y; Yang Y; Xie G; Feng Q
J Exp Clin Cancer Res; 2020 Dec; 39(1):269. PubMed ID: 33256799
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression.
Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405
[TBL] [Abstract][Full Text] [Related]
18. Histone demethylase KDM5D represses the proliferation, migration and invasion of hepatocellular carcinoma through the E2F1/TNNC1 axis.
Li L; Zhu G; Gong C; Hu M; Tan K; Jiang L; Li Y; Zhu X; Xie P; Chen X; Yang X
Antioxid Redox Signal; 2024 Mar; ():. PubMed ID: 38504588
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNA SNHG12 suppresses cell proliferation, migration and invasion in breast cancer by sponging miR-451a.
Dong Y; Wang G
Int J Clin Exp Pathol; 2020; 13(3):393-402. PubMed ID: 32269676
[TBL] [Abstract][Full Text] [Related]
20. Long Non-coding RNA SNHG12, a New Therapeutic Target, Regulates miR-199a-5p/Klotho to Promote the Growth and Metastasis of Intrahepatic Cholangiocarcinoma Cells.
Yang HG; Wang TP; Hu SA; Hu CZ; Jiang CH; He Q
Front Med (Lausanne); 2021; 8():680378. PubMed ID: 34239888
[No Abstract] [Full Text] [Related]
[Next] [New Search]
